4//SEC Filing
Van Plew Daniel P 4
Accession 0001968202-24-000066
CIK 0000872589other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:15 PM ET
Size
28.4 KB
Accession
0001968202-24-000066
Insider Transaction Report
Form 4
Van Plew Daniel P
SVP & GM, Indust Ops&Prod Supp
Transactions
- Sale
Common Stock
2024-02-14$947.81/sh−240$227,474→ 21,215 total - Sale
Common Stock
2024-02-14$945.81/sh−95$89,852→ 21,455 total - Sale
Common Stock
2024-02-14$939.60/sh−750$704,700→ 29,397 total - Sale
Common Stock
2024-02-14$943.51/sh−2,691$2,538,985→ 22,170 total - Sale
Common Stock
2024-02-14$950.45/sh−375$356,419→ 20,578 total - Sale
Common Stock
2024-02-14$941.41/sh−275$258,888→ 24,861 total - Sale
Common Stock
2024-02-14$937.94/sh−439$411,756→ 30,373 total - Sale
Common Stock
2024-02-14$938.13/sh−226$212,017→ 30,147 total - Sale
Common Stock
2024-02-14$940.44/sh−4,261$4,007,215→ 25,136 total - Sale
Common Stock
2024-02-14$944.30/sh−620$585,466→ 21,550 total - Sale
Common Stock
2024-02-14$948.70/sh−150$142,305→ 21,065 total - Sale
Common Stock
2024-02-14$949.07/sh−112$106,296→ 20,953 total - Sale
Common Stock
2024-02-14$951.77/sh−200$190,354→ 20,378 total
Holdings
- 1,084(indirect: By 401(k))
Common Stock
- 12,376(indirect: 2023 GRAT)
Common Stock
Footnotes (13)
- [F1]Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F10]Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001411984
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:15 PM ET
- Size
- 28.4 KB